External News
Source: Solr
- Score: 1Internal Medicine Annual Report
Multidisciplinary CMCO Making Strides
- Score: 1
Smilow Shares with Primary Care: Soft Tissue/Bony Lumps
- Score: 1healthbook
healthbook ASCO 2024 Newsroom
- Score: 1Oncology News Central
“Groundbreaking” Data Upend Practice in Lung Cancer: Consolidation Durvalumab Extends Survival in LS-SCLC
- Score: 1
Annual Fellows Research Day 2024
- Score: 1
New Survival Data From a Lung Cancer Study to be Revealed by Yale Cancer Center Expert at International Conference
- Score: 1OBR Oncology
FDA Grants Accelerated Approval to First Bispecific for Small Cell Lung Cancer
- Score: 1OncLive
Applying the Heterogeneous Approach From NSCLC to SCLC
- Score: 1
New Research and Treatment Advances From Yale Cancer Center to be Presented at the World’s Largest Cancer Research Conference
- Score: 1OBR Oncology
Which NSCLC Patients Benefit Most From Chemo Plus Osimertinib? New Data Offer Clues
